Key Insights

Highlights

Success Rate

86% trial completion

Published Results

32 trials with published results (15%)

Research Maturity

101 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.6%

16 terminated out of 210 trials

Success Rate

86.3%

-0.2% vs benchmark

Late-Stage Pipeline

6%

12 trials in Phase 3/4

Results Transparency

32%

32 of 101 completed with results

Key Signals

32 with results86% success16 terminated

Data Visualizations

Phase Distribution

143Total
Not Applicable (53)
Early P 1 (4)
P 1 (48)
P 2 (26)
P 3 (11)
P 4 (1)

Trial Status

Completed101
Recruiting29
Unknown27
Active Not Recruiting22
Terminated16
Not Yet Recruiting7

Trial Success Rate

86.3%

Benchmark: 86.5%

Based on 101 completed trials

Clinical Trials (210)

Showing 20 of 20 trials
NCT01432847Recruiting

Cell Collection to Study Eye Diseases

NCT03374657Phase 1CompletedPrimary

A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

NCT05926583Phase 3Active Not RecruitingPrimary

A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa

NCT00254605RecruitingPrimary

Retinal Imaging in Patients With Inherited Retinal Degenerations

NCT02617966Recruiting

Rod and Cone Mediated Function in Retinal Disease

NCT07408232Phase 1Active Not RecruitingPrimary

A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)

NCT02435940Recruiting

Inherited Retinal Degenerative Disease Registry

NCT05748873Phase 1Active Not RecruitingPrimary

Promising ROd-cone DYstrophy Gene therapY

NCT05355415Recruiting

Adaptive Optics Imaging of Outer Retinal Diseases

NCT06323772Active Not RecruitingPrimary

Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

NCT01866371Recruiting

High Resolution Retinal Imaging

NCT05282953Phase 1CompletedPrimary

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

NCT05537220Phase 3Active Not RecruitingPrimary

Oral N-acetylcysteine for Retinitis Pigmentosa

NCT06628947Phase 2RecruitingPrimary

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

NCT07228793RecruitingPrimary

Natural History Study of Patients With EYS-Associated RP

NCT05392179Phase 2CompletedPrimary

A Study in Subjects With Retinitis Pigmentosa

NCT06891885Phase 1RecruitingPrimary

A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

NCT05589714Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

NCT06574997UnknownPrimary

Expanded Access Program for RP in Adults

NCT05573984Active Not RecruitingPrimary

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Scroll to load more

Research Network

Activity Timeline